Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 23/03/18 → 31/03/23 |
Funding
- Eisai Europe Limited: £3,801.55
- Eisai Europe Limited: £31,342.45
Post-adoption surveillance audit of new medicines for metastatic breast cancer in the real world
- Hall, Peter (Principal Investigator)